XML 53 R41.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Summary of Stock Options Awards and Restricted Stock Grants (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Weighted average exercise price, granted $ 0.86 $ 1.32
Share-Based Payment Arrangement, Option [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Options outstanding, beginning balance 1,063,482  
Weighted average exercise price, beginning balance $ 2.61  
Options outstanding, granted 152,000  
Weighted average exercise price, granted $ 0.86  
Options outstanding, vested and issued  
Weighted average exercise price, vested and issued  
Options outstanding, Terminated (209,152)  
Weighted average exercise price, Terminated $ 1.75  
Options outstanding, ending balance 1,006,330  
Weighted average exercise price, ending balance $ 2.53  
Weighted average contractual terms 8 years 8 months 12 days  
Options outstanding, aggregate intrinsic value  
Options outstanding, exercisable 661,985  
Weighted average exercise price, exercisable $ 3.13  
Weighted average contractual terms, exercisable 8 years 6 months  
Options outstanding, aggregate intrinsic value, exercisable $ 119,818  
Restricted Stock [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Non-vested stock awards, beginning balance 32,100  
Weighted average grant date fair value, beginning balance $ 1.23  
Non-vested stock awards, granted  
Weighted average grant date fair value, granted  
Non-vested stock awards, vested and issued 1,100  
Weighted average grant date fair value, vested and issued $ 1.32  
Non-vested stock awards, Terminated  
Weighted average grant date fair value, Terminated  
Non-vested stock awards, ending balance 31,000  
Weighted average grant date fair value, ending balance $ 1.24